Pharmacokinetics of Siddha Antidiabetic Polyherbal Formulation Madhumega Chooranam in Healthy Volunteers

Background Madhumega Chooranam (MMC), a traditional Siddha polyherbal formulation, is used for diabetes management. Understanding its pharmacokinetics is crucial for evaluating its efficacy and safety in clinical practice. This study aimed to assess the pharmacokinetics of gallic acid, a key component of MMC. Methodology Ten healthy volunteers were selected based on their willingness to participate and the absence of significant clinical conditions, including liver, kidney, heart, peripheral nerve disorders, or allergies. During the screening phase, participants with abnormal laboratory results in blood chemistry, hematology, or urine analysis were excluded. All participants provided written informed consent before the initiation of the study. Participants were administered a single oral dose of 6 g of MMC. Blood samples were collected at predetermined intervals over 24 hours to estimate gallic acid content used as a pharmacokinetic marker. Results Gallic acid concentration peaked in some participants' plasma samples at varying intervals post-administration, indicating individual differences in absorption and metabolism. In contrast, no gallic acid peaks were detected in the plasma samples of three participants, suggesting potential variability in metabolic response or rapid clearance. Conclusions The study's findings underscore the complexity of MMC's pharmacokinetics, influenced by individual metabolic and genetic factors. Additionally, this research highlights the need for an interdisciplinary approach, integrating traditional medicine with modern pharmacogenomics and gut microbiota studies, to fully understand Siddha formulations' pharmacokinetics and therapeutic potential. Future studies should focus on larger sample sizes and consider genetic and dietary factors to enhance the understanding of MMC's efficacy and safety in diverse populations.